Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.

[1]  R. Brooner,et al.  DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM , 2002, Substance use & misuse.

[2]  R. Brooner,et al.  Influence of Antisocial Personality Subtypes on Drug Abuse Treatment Response , 2001, The Journal of nervous and mental disease.

[3]  S. Strathdee,et al.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. , 2000, Social science & medicine.

[4]  R. Brooner,et al.  Influence of Psychiatric Comorbidity on HIV Risk Behaviors , 2000, Journal of addictive diseases.

[5]  M. Stein,et al.  Depression among needle exchange program and methadone maintenance clients. , 2000, Journal of substance abuse treatment.

[6]  W. H. Hall,et al.  Effective medical treatment of opiate addiction , 1998 .

[7]  R. Brooner,et al.  Drug abuse treatment success among needle exchange participants. , 1998, Public health reports.

[8]  G. Woody,et al.  Drug abuse treatment as AIDS prevention. , 1998, Public health reports.

[9]  D. Vlahov,et al.  The role of needle exchange programs in HIV prevention. , 1998, Public health reports.

[10]  R. Heimer.  Can syringe exchange serve as a conduit to substance abuse treatment? , 1998, Journal of substance abuse treatment.

[11]  R. Brooner,et al.  Preliminary evidence of good treatment response in antisocial drug abusers. , 1998, Drug and alcohol dependence.

[12]  R Brookmeyer,et al.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[13]  D. Simpson,et al.  Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). , 1997 .

[14]  Julio S. G. Montaner,et al.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.

[15]  S. Dinwiddie,et al.  Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. , 1996, Drug and alcohol dependence.

[16]  Samuel R Friedman,et al.  HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.

[17]  R. Brooner,et al.  Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. , 1996, Drug and alcohol dependence.

[18]  M. Alter,et al.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.

[19]  A. Alterman,et al.  Gender differences in diagnosing antisocial personality disorder in methadone patients. , 1995, The American journal of psychiatry.

[20]  A. Alterman,et al.  Treatment Response of Antisocial Substance Abusers , 1995, The Journal of nervous and mental disease.

[21]  J. Gorman,et al.  Psychopathology in male and female intravenous drug users with and without HIV infection. , 1994, The American journal of psychiatry.

[22]  J C Perry,et al.  Problems and considerations in the valid assessment of personality disorders. , 1992, The American journal of psychiatry.

[23]  M Davies,et al.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. , 1992 .

[24]  R. Bland.  Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1992 .

[25]  L. Sobell.  Drug Abuse Treatment: A National Study of Effectiveness, Robert L. Hubbard. 1990. University of North Carolina Press, Chapel Hill, NC. 260 pages. ISBN: 0-8078-1864. $29.95 , 1991 .

[26]  J. Ball,et al.  The Effectiveness of Methadone Maintenance Treatment , 1991, Springer New York.

[27]  R. Brooner,et al.  Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. , 1991, Drug and alcohol dependence.

[28]  R. Brooner,et al.  Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. , 1990, Drug and alcohol dependence.

[29]  R. Malow,et al.  Personality disorders classification and symptoms in cocaine and opioid addicts. , 1989 .

[30]  M. Weissman,et al.  Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. , 1986, Archives of general psychiatry.

[31]  G. Woody,et al.  Sociopathy and psychotherapy outcome. , 1985, Archives of general psychiatry.

[32]  E. Khantzian,et al.  DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. , 1985, Archives of general psychiatry.

[33]  G. Woody,et al.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. , 1983, Archives of general psychiatry.

[34]  M. Weissman,et al.  Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. , 1982, Archives of general psychiatry.

[35]  M. Weissman,et al.  Heterogeneity of psychiatric diagnosis in treated opiate addicts. , 1982, Archives of general psychiatry.

[36]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[37]  M. Kidorf,et al.  Contingent access to clinic privileges reduces drug abuse in methadone maintenance patients. , 1999 .

[38]  K. Silverman,et al.  Motivating behavior change among illicit-drug abusers: Research on contingency management interventions. , 1999 .

[39]  R. Brooner,et al.  Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. , 1998, Journal of consulting and clinical psychology.

[40]  R. Brooner,et al.  Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.

[41]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .

[42]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[43]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[44]  R. Brooner,et al.  Psychiatric distress in antisocial drug abusers: relation to other personality disorders. , 1994, Drug and alcohol dependence.

[45]  R. Brooner,et al.  Antisocial personality disorder and HIV infection among intravenous drug abusers. , 1993, The American journal of psychiatry.

[46]  M. Moffitt,et al.  Missed psychiatric appointments: who returns and who stays away. , 1993, The American journal of psychiatry.

[47]  Nace Ep,et al.  Axis II comorbidity in substance abusers. , 1991 .